PDA for Antidepressant Use in Pregnancy

NACompletedINTERVENTIONAL
Enrollment

462

Participants

Timeline

Start Date

October 18, 2018

Primary Completion Date

July 31, 2024

Study Completion Date

April 30, 2025

Conditions
PregnancyDepression
Interventions
BEHAVIORAL

Electronic Patient Decision Aid

"The electronic PDA is an interactive website with 3 main sections:~1. Review of depression treatment options (non-pharmacological and pharmacological) along with their respective risks and benefits.~2. Interactive values clarification exercises to help women determine which risks and benefits are most important to them.~3. Exercises to help women consider how partners, family, providers and the social context impacts decision-making.~A summary of how a woman feels about each option along with risks and benefits is generated which can be provided to treating clinicians for use in follow-up.~A printable pdf with standard published information and resources is also included."

BEHAVIORAL

Standard Resource Sheet

A control group aims to isolate the PDA's effects from time and clinical care. Controls login to the study website and receive the same printable pdf as in the PDA so that they can access standard publicly available information/resources, even if they will not receive the PDA.

Trial Locations (1)

M5S1B2

Women's College Hospital, Toronto

All Listed Sponsors
collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

lead

Women's College Hospital

OTHER

NCT03632863 - PDA for Antidepressant Use in Pregnancy | Biotech Hunter | Biotech Hunter